|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-2-25
|
|
pubmed:abstractText |
To evaluate the potential of topical iganidipine ophthalmic solution to exert Ca(2+)-antagonistic activity in the posterior parts of the eye without inducing systemic effects, ocular and periocular penetration of topically instilled iganidipine was studied in pigmented rabbits.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0146-0404
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1169-77
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12601046-Administration, Topical,
pubmed-meshheading:12601046-Animals,
pubmed-meshheading:12601046-Anterior Eye Segment,
pubmed-meshheading:12601046-Autoradiography,
pubmed-meshheading:12601046-Betaxolol,
pubmed-meshheading:12601046-Calcium,
pubmed-meshheading:12601046-Calcium Channel Blockers,
pubmed-meshheading:12601046-Calcium Channels,
pubmed-meshheading:12601046-Endothelin-1,
pubmed-meshheading:12601046-Eye,
pubmed-meshheading:12601046-Injections, Intravenous,
pubmed-meshheading:12601046-Ophthalmic Solutions,
pubmed-meshheading:12601046-Piperazines,
pubmed-meshheading:12601046-Pyridines,
pubmed-meshheading:12601046-Rabbits,
pubmed-meshheading:12601046-Retina,
pubmed-meshheading:12601046-Retinal Artery,
pubmed-meshheading:12601046-Solubility,
pubmed-meshheading:12601046-Vasoconstriction,
pubmed-meshheading:12601046-Vasodilator Agents
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation.
|
|
pubmed:affiliation |
Eye Clinic, Omiya Red Cross Hospital, Omiya, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
